Seeing Is Believing
Currently out of the existing stock ratings of Yuan Zhi, 3 are a HOLD (4.84%), 1 are a SELL (1.61%), 58 are a BUY (93.55%).
Analyst Yuan Zhi, currently employed at B. RILEY, carries an average stock price target met ratio of 48.88% that have a potential upside of 37.67% achieved within 78 days.
Yuan Zhi’s has documented 118 price targets and ratings displayed on 17 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on CATX, Perspective Therapeutics at 18-Mar-2026.
Analyst best performing recommendations are on HYPR (HYPERFINE).
The best stock recommendation documented was for HYPR (HYPERFINE) at 8/14/2025. The price target of $1.4 was fulfilled within 1 day with a profit of $0.05 (3.45%) receiving and performance score of 34.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Nov-2021
$44
$21.37 (94.43%)
$44
21 days ago
(17-Mar-2026)
3/24 (12.5%)
$21.97 (99.73%)
162
Buy Since 05-Feb-2026
$45
$22.37 (98.85%)
$50
2 months 2 days ago
(05-Feb-2026)
9/12 (75%)
$17.15 (61.58%)
56
Buy Since 25-Nov-2025
$45
$22.37 (98.85%)
$35
4 months 13 days ago
(25-Nov-2025)
1/2 (50%)
$6.9 (18.11%)
110
Buy Since 31-Mar-2022
$79
$56.37 (249.09%)
$68
2 years 2 months 6 days ago
(01-Feb-2024)
0/5 (0%)
$12.87 (19.46%)
Hold
$55
$-10.11 (-15.53%)
$45
2 years 4 months 24 days ago
(14-Nov-2023)
6/8 (75%)
$0.55 (1.01%)
71
Which stock is Yuan Zhi is most bullish on?
Which stock is Yuan Zhi is most reserved on?
What Year was the first public recommendation made by Yuan Zhi?